Cytosorbents (CTSO) Current Leases (2018 - 2026)
Cytosorbents (CTSO) posted Current Leases of $565000.0 for Q1 2026, up 4.44% on a QoQ basis from $541000.0 in Q4 2025, and up 19.23% year-over-year from $473889.0 in Q1 2025.
Cytosorbents (CTSO) Current Leases (2018 - 2026) Analysis & Trends
Cytosorbents' Current Leases history runs 9 years deep, the most recent figure standing at $565000.0 for Q1 2026.
- Quarterly Current Leases rose 19.23% year-over-year to $565000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $565000.0 (up 19.23% YoY) and the FY2025 annual result came in at $541000.0, up 19.43% from the prior year.
- Current Leases was $565000.0 for Q1 2026 at Cytosorbents, up from $541000.0 in the prior quarter.
- Across five years, Current Leases topped out at $565000.0 in Q1 2026 and bottomed at $108939.0 in Q4 2022.
- A 5-year average of $375806.6 and a median of $416861.0 in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases plunged 80.91% — and 2024, when it surged 268.59%.
- Cytosorbents' Current Leases stood at $108939.0 in 2022, then jumped by 242.98% to $373636.0 in 2023, then climbed by 21.24% to $453000.0 in 2024, then grew by 19.43% to $541000.0 in 2025, then grew by 4.44% to $565000.0 in 2026.
- Business Quant data shows CTSO's Current Leases at $565000.0 in Q1 2026, $541000.0 in Q4 2025, and $518000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 20.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | 565,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 565,000.00 |
| Dec 31, 2025 | 541,000.00 |
| Sep 30, 2025 | 518,000.00 |
| Jun 30, 2025 | 495,000.00 |
| Mar 31, 2025 | 473,889.00 |
| Dec 31, 2024 | 453,000.00 |
| Sep 30, 2024 | 431,997.00 |
| Jun 30, 2024 | 412,067.00 |
| Mar 31, 2024 | 392,617.00 |
| Dec 31, 2023 | 373,636.00 |
| Sep 30, 2023 | 117,204.00 |
| Jun 30, 2023 | 114,382.00 |
| Mar 31, 2023 | 111,627.00 |
| Dec 31, 2022 | 108,939.00 |
| Sep 30, 2022 | 376,529.00 |
| Jun 30, 2022 | 416,861.00 |
| Mar 31, 2022 | 486,964.00 |
| Dec 31, 2021 | 570,566.00 |
| Sep 30, 2021 | 265,675.00 |
| Jun 30, 2021 | 251,524.00 |